Hemorrhaging focal encephalitis under fingolimod (FTY720) treatment: a case report.
Leypoldt
F
F
Department of Neurology, University Hospital Hamburg, Hamburg, Germany. F.Leypoldt@uke.uni-hamburg.de
Münchau
A
A
Moeller
F
F
Bester
M
M
Gerloff
C
C
Heesen
C
C
D000328:Adult; D001921:Brain / Q000473:pathology; D002543:Cerebral Hemorrhage / Q000139:chemically induced* / Q000473:pathology; D003287:Contrast Media; D004660:Encephalitis / Q000139:chemically induced* / Q000473:pathology; D017029:Epilepsy, Complex Partial / Q000139:chemically induced / Q000503:physiopathology; D005260:Female; D000068876:Fingolimod Hydrochloride; D005682:Gadolinium; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008279:Magnetic Resonance Imaging; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000150:complications / Q000188:drug therapy; D009336:Necrosis; D011409:Propylene Glycols / Q000009:adverse effects*; D013110:Sphingosine / Q000009:adverse effects / Q000031:analogs & derivatives*
D003287:Contrast Media; D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D005682:Gadolinium; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine